AR antagonist 13 (compound 19) is an androgen receptor (AR) antagonist that inhibits prostate cancer cell growth, achieving an inhibition rate of over 71.5% at a concentration of 10 µM.
Target:
Androgen Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
